39658-41-8

Basic information

• Product Name: Ethyl 6-aminonicotinate
• Synonyms: Ethyl 6-aminonicotinate 98%;ETHYL 6-AMINOPYRIDINE-3-CARBOXYLATE;Ethyl 6-aminonicotinate ,98%;6-Amino-nicotinic acid ethyl esterr;6-aminopyridine-3-carboxylate;3-pyridinecarboxylic acid, 6-aMino-, ethyl ester;ETHYL 2-AMINOPYRIDINE-5-CARBOXYLATE;ETHYL 2-AMINO-5-PYRIDINECARBOXYLATE
• CAS NO: 39658-41-8
• Molecular Formula: C₈H₁₀N₂O₂
• Molecular Weight: 166.18
• Product Categories: Amines;blocks;Carboxes;Pyridines;Acids and Derivatives;Amines and Anilines;pharmacetical
• Mol File: 39658-41-8.mol
• Article Data: 30

Chemical Properties

• Melting Point: 145-147
• Boiling Point: 314.7 °C at 760 mmHg
• Flash Point: 144.1 °C
• Appearance: /
• Density: 1.192 g/cm³
• Vapor Pressure: 0.000457mmHg at 25°C
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 4.88±0.13(Predicted)
• CAS DataBase Reference: Ethyl 6-aminonicotinate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 6-aminonicotinate(39658-41-8)
• EPA Substance Registry System: Ethyl 6-aminonicotinate(39658-41-8)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Safety Statements: 26
• Hazardous Substances Data: 39658-41-8(Hazardous Substances Data)

Usage

General Description

Ethyl 6-aminonicotinate, also known as N-ethyl-6-aminonicotinate or Nicotinic acid, ethyl ester, 6-amino, is a synthetic compound characterized by its ethanol structure combined with a nicotinic acid that has been substituted with an amino group at position 6. It's an organic compound belonging to the pyridines class and its molecular formula is C8H10N2O2. It is generally used in scientific research and experimentations, particularly in the pharmaceutical industry for drug discovery and development. However, detailed information about its potential applications and safety in medical treatments is limited, requiring further studies and investigations.

InChI:InChI=1/C8H10N2O2/c1-2-12-8(11)6-3-4-7(9)10-5-6/h3-5H,2H2,1H3,(H2,9,10)/p+1

Upstream product

• 3167-49-5 6-aminonicotinic acid 
• 30062-31-8 2-(ethoxycarbonyl)pyridine-1-oxide 
• 49608-01-7 6-chloro-3-pyridinecarboxylic acid ethyl ester 
• 64-17-5 ethanol 
• 231958-14-8 6-[(tert-butoxycarbonyl)amino]nicotinic acid 
• 75-03-6 ethyl iodide 
• 69142-57-0 2-[1-(5-Ethoxycarbonyl-pyridin-2-ylamino)-meth-(E)-ylidene]-succinic acid diethyl ester 
• 69142-56-9 2-[1-(5-Ethoxycarbonyl-pyridin-2-ylamino)-meth-(Z)-ylidene]-succinic acid diethyl ester 
• 329-89-5 6-aminonicotinic amide 

Downstream Products

• 87745-91-3 Ethyl 2-methyl-3-ethyl-4-oxo-4H-pyrido<1,2-a>pyrimidine-7-carboxylate hydrochloride 
• 113293-71-3 (6-amino-3-pyridinyl)methanol 
• 158001-04-8 imidazo[1,2-a]pyridine-6-carboxylic acid ethyl ester 
• 543740-75-6 6-amino-5-iodonicotinic acid ethyl ester 
• 169280-82-4 6-((tert-butoxycarbonyl)amino)nicotinic acid ethyl ester 
• 305329-79-7 6-amino-5-chloronicotinic acid ethyl ester 
• 372147-65-4 (Z)-ethyl α-[(triphenylphosphoranylidene)amino]-β-(imidazo[1,2-a]pyridin-6-yl)propenoate 
• 132213-07-1 6-(hydroxymethyl)imidazo[1,2-a]pyridine 
• 116355-16-9 6-imidazo<1,2-a>pyridinecarboxaldehyde 
• 180416-31-3 N-[5-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)-2-pyridinyl]-5-fluoro-2-methylbenzamide 
• 200879-03-4 N-[5-(5H-pyrrolo[2, 1-c][1, 4]benzodiazepin-10(11H)-ylcarbonyl)-2-pyridinyl]-2-nitrobenzamide 

Relevant articles and documents

Mild, General, and Regioselective Synthesis of 2-Aminopyridines from Pyridine N -Oxides via N -(2-Pyridyl)pyridinium Salts

A synthesis of 2-aminopyridines from pyridine N-oxides via their corresponding N-(2-pyridyl)pyridinium salts has been demonstrated and investigated. The reaction sequence features a highly regioselective conversion of the N-oxide into its pyridinium salt

Sulfa drug haptens and its preparation method and application

The invention discloses a hapten, and a preparation method and application thereof, particularly a sulfonamide hapten. The invention also discloses a preparation method and application of the hapten. The kit quick detection product established on the basi

ISOPROPYL TRIAZOLO PYRIDINE COMPOUNDS

The present invention provides a compound of the Formula (I) below: Wherein R1 is selected from the group consisting of H, CH3, CN, CH2CN, C(CH3)2CN, and F; R2 is selected from the group consisting of H, O(C1-C3alkyl)R5, CH2CN, and CN; R3 is selected from the group consisting of H, OCH3, CN, C(CH3)2CN, and CH2CN; R4 is selected from the group consisting of H and CH3; R5 is selected from the group consisting of H, CN, C(CH3)2CN, OCH3, S(O)2CH3, and C(CH3)2OH; provided that at least one selected from the group consisting of R1, R2, R3 and R4 is H; or a pharmaceutically acceptable salt thereof, methods of treating diabetes using the compound and a process for preparing the compound.